FdaApplication

ANDA 214949

Back to search

Identifiers

Properties

PropertyValue
applicant_nameLEADING PHARMA LLC
application_typeANDA
approval_date2022-02-28

Products (1)

ProductActive ingredientStrengthDosage form
OSELTAMIVIR PHOSPHATEOSELTAMIVIR PHOSPHATEEQ 6MG BASE/MLFOR SUSPENSION;ORAL

1 product